Patients with severe/critical COVID-19 were also characterized by an increased activation of TLR2 pathway with enhanced expression of TLR2 RNA in the circulating mononuclear cells, when compared with moderate COVID-19 or healthy subjects. This evidence concerns the gene TLR2 and COVID-19.